US Patent 11746103 ALK-5 inhibitors and uses thereof

US Patent 7332582 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency

US Patent 7488802 Antibodies against PD-1

US Patent 7632947 Pyrimidopyrimidine derivatives, organic thin film transistors using pyrimidopyrimidine derivatives and method for fabricating the same

US Patent 7695715 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases

US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

US Patent 8168179 Treatment method using anti-PD-L1 antibody

US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture

US Patent 8354509 Antibodies to human programmed death receptor PD-1

US Patent 8460927 B7-H1 antibodies and method of use

US Patent 8552154 Anti-PD-L1 antibodies and uses therefor

US Patent 8552156 Anti-TIM-3 antibody

US Patent 8686119 Variants of humanized immunomodulatory monoclonal antibodies

US Patent 8735553 Anti-PD1 antibodies and their use as therapeutics and diagnostics

US Patent 8779108 Targeted binding agents against B7-H1

US Patent 8841418 Antibodies that specifically bind to TIM3

US Patent 8907053 Immunosuppression modulating compounds

US Patent 8927697 PD-1 specific antibodies and uses thereof

US Patent 8993731 PD-1 antibody

US Patent 9102727 Human anti-PD-1 antibodies and uses therefor

US Patent 9163087 Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions

US Patent 9175082 Antigen binding proteins that bind PD-L1

US Patent 9205148 Antibodies and other molecules that bind B7-H1 and PD-1

US Patent 9244059 Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease

US Patent 9505839 Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

C07D 413/14

C07D 405/14

C07D 403/14

C07D 403/12

C07D 401/14